Transplantation - Global Strategic Business Report

The global market for Transplantation is estimated at US$14 Billion in 2023 and is projected to reach US$22.7 Billion by 2030, growing at a CAGR of 7.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Organ Transplantation segment, which is expected to reach US$8.6 Billion by 2030 with a CAGR of 6.9%. The Tissue Transplantation segment is also set to grow at 7.2% CAGR over the next 7 years.
• Regional Analysis: Gain insights into the U.S. market, estimated at $3.7 Billion in 2023, and China, forecasted to grow at an impressive 11.7% CAGR to reach $5.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Transplantation Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Transplantation Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Transplantation Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Acelity LP, Inc., Avioq, Inc., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 118 Featured):

• Abbott Laboratories, Inc.
• Acelity LP, Inc.
• Avioq, Inc.
• AxoGen, Inc.
• BD Biosciences
• BioLife Solutions Inc.
• Bio-Rad Laboratories, Inc.
• CareDx, Inc.
• Carmat SA
• Chronix Biomedical
• Dr. Franz Kohler Chemie GmbH
• F. Hoffmann-La Roche AG
• GenDx
• Histogenics Corporation
• Illumina, Inc.
• Luminex Corporation
• Medipex Limited
• Miromatrix Medical Inc.
• Nano Dimension Ltd.
• Organovo Holdings, Inc.
• Ortho Clinical Diagnostics
• Oxford Immunotec Global PLC
• Pacific Biosciences of California, Inc.
• Pandorum Technologies Pvt. Ltd.
• Qiagen NV
• Siemens Healthineers
• SynCardia
• Thermo Fisher Scientific, Inc.
• Transplant Biomedicals S.L.
• XVIVO Perfusion AB

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.